Skip to main content

Kailos PGxComplete

Kailos has launched PGxComplete, a comprehensive, full panel, gene-based test that the company is offering for $99 through November 30. The panel tests 20 different classes of medications to reveal how one's body responds to more than 50 types of medications, including antidepressants, opioids, HIV/AIDS treatment, and cancer therapy. The panel uses advanced technology that harnesses DNA sequencing and enables a more holistic view of a person's gene-based medical information, said Kailos in a statement. The company launched its first pharmacogenetics test (the Kailos test, formerly called Praxis) this past June. 

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.